Thrombopoietin Receptor Levels in Tumor Cell Lines and Primary Tumors

Thrombopoietin (TPO) receptor agonists represent a new approach for the treatment of thrombocytopenia, which may develop as a consequence of immune thrombocytopenia, chemotherapy treatment, chronic hepatitis C infection, or myelodysplastic syndromes. There are concerns that use of certain growth fac...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Erickson-Miller, Connie L., Chadderton, Antony, Gibbard, Anna, Kirchner, Jennifer, Pillarisetti, Kodandaram, Baker, Katherine, Pandite, Lini, El-Hariry, Iman, Mostafa Kamel, Yasser, Liu, Yuan, Martin, Anne-Marie, Messam, Conrad
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2010
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3026977/
https://ncbi.nlm.nih.gov/pubmed/21318160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/135354
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires